Mark Coleman, Director at Axsome Therapeutics, Inc. (AXSM), sold 3,000 shares at $107.49 ($322K) on 2025-05-20, disclosed to the SEC on 2025-05-20.
Open-market sale of $322k AXSM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AXSM | SELL | 2026-02-27 | $4.0M | — | Filing → |
| AXSM | BUY | 2025-09-09 | $263K | — | Filing → |
| AXSM | SELL | 2025-05-29 | $1.6M | — | Filing → |